Resumen
El número de pacientes con enfermedad renal crónica avanzada/terminal (ERCT) con alguna modalidad de terapia de reemplazo renal (TRR) ha ido en ascenso. A nivel mundial, la diálisis peritoneal (DP) representa el 11% del total de pacientes con TRR. Las diferentes opciones de TRR se han asociado con un mayor riesgo para desarrollar complicaciones infecciosas, metabólicas y nutricionales, reportándose cifras alarmantes de desgaste proteico energético (DPE) que oscilan entre 32-49% en pacientes en DP.
El tipo de transportador peritoneal juega un rol importante en el desarrollo de complicaciones nutricionales, donde el transportador alto, en comparación con el lento o bajo, se ha asociado con un mayor riesgo nutricional al incrementar el riesgo de sobrecarga de volumen, hipertensión e inflamación; así como mayor pérdida de proteínas en el dializado por el mayor número de recambios que caracteriza su prescripción. Por tal motivo, el profesional de la nutrición debe considerar diversos aspectos para lograr un abordaje nutricional individualizado a partir de las características del paciente, en el que conocer el tipo de transportador peritoneal es fundamental. El objetivo del presente trabajo es realizar una revisión de la evidencia disponible hasta la fecha respecto a la terapia nutricional del paciente con diálisis peritoneal, así como analizar algunos aspectos básicos de la terapia dialítica.
Abstract
The number of patients with advanced / end-stage chronic kidney disease (ESRD) with some modality of renal replacement therapy (RRT) has been on the rise significantly. Peritoneal dialysis (PD) represents 11% of the world dialysis population. Different options for RRT have been associated with a greater risk of developing complications, such infections, metabolic alterations and nutritional complications, specifically a higher incidence of protein-energy wasting (PEW), ranging from 32 to 49% in PD patients. Peritoneal transporter type plays an important role in the development of nutritional complications, where the high transporter compared to the slow or low transporter has been associated with a higher nutritional risk by increasing the risk of volume overload, hypertension, and inflammation; as well as greater loss of proteins in the dialysate due to the greater number of replacements that characterize its prescription. Nutrition specialists needs to consider diverse aspects to achieve an individualized nutritional approach based on the characteristics of the patient, where knowing peritoneal transporter type is essential. The aim of this study is to review the evidence available to date regarding nutritional therapy in patients with peritoneal dialysis, as well as to analyze some basic aspects of dialysis therapy.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019;322(13):1294-1304. doi: 10.1001/jama.2019.14745
Evans M, Lopau K. The transition clinic in chronic kidney disease care. Nephr Dial Transplant. 2020;35(S2):ii4-ii10. doi: 10.1093/ndt/gfaa022
Li PK-T, Chow KM, Van de Luijtgaarden MWM, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90-103. doi:10.1038/nrneph.2016.181
Hansson JH, Watnick S. Update on Peritoneal Dialysis: Core Curriculum 2016. Am J Kidney Dis. 2016;67(1):151-164. doi: 10.1053/j.ajkd.2015.06.031
Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress. Biomolecules. 2020;10(5). doi: 10.3390/biom10050768
Mejías Mava P, Prats Valencia M, Borrás Sans M. Indicaciones y modalidades de diálisis peritoneal. En: Lorenzo V, López Gómez JM (Eds). Nefrología al día. http://www.nefrologiaaldia.org/es-articulo-indicaciones-modalidades-dialisis-peritoneal-229.
Roumeliotis A, Roumeliotis S, Leivaditis K, Salmas M, Eleftheriadis T, Liakopoulos V. APD or CAPD: one glove does not fit all. APD or CAPD: one glove does not fit all. Int Urol Nephrol. 2020: 1-12. doi: 10.1007/s11255-020-02678-6
Macía Heras M, Coronel Díaz F. Diálisis peritoneal: definición, membrana, transporte peritoneal, catéteres, conexiones y soluciones de diálisis. En: Lorenzo V, López Gómez JM (Eds). Nefrología al día. https://www.revistanefrologia.com/en-pdf-XX34216421200168X. Acceso Mayo 17, 2021.
Heaf JG. Peritoneal transport: getting more complicated. Nephrol Dial Transplant. 2012;27(12):4248-4251. doi: 10.1093/ndt/gfs385
Carrero JJ, Thomas F, Nagy K, et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380-392. doi: 10.1053/j.jrn.2018.08.006
Leal Escobar G, Osuna Padilla IA, Cano Escobar KB, Moguel González B, Pérez Grovas HA, Ruiz Ubaldo S. Phase angle and mid arm circumference as predictors of protein energy wasting in renal replacement therapy patients. Nutr Hosp. 2019;36(3):633-639. doi:10.20960/nh.2463
Hanna RM, Ghobry L, Wassef O, Rhee CM, Kalantar-Zadeh K. A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease. Blood Purif. 2020;49(1-2):202-211. doi:10.1159/000504240
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney International. 2008;73(4):391-398. doi: 10.1038/sj.ki.5002585
Guan J-C, Bian W, Zhang X-H, Shou Z-F, Chen J-H. Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis. Chin Med J. 2015;128(7):859-864. doi: 10.4103/0366-6999.154275
Avila-Carrasco L, Pavone MA, González E, Aguilera-Baca Á, Selgas R, Del Peso G, et al. Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis. Front Physiol. 2019;10:630. doi: 10.3389/fphys.2019.00630
Kosmadakis G, Albaret J, da Costa Correia E, Somda F, Aguilera D. Gastrointestinal Disorders in Peritoneal Dialysis Patients. Am J Nephrol. 2018;48(5):319-325. doi: 10.1159/000494145
Yoowannakul S, Harris LS, Davenport A. Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status. Ther Apher Dial. 2018;22(2):171-177. doi: 10.1111/1744-9987.12647
Rodríguez-Carmona A, Pérez-Fontán M, Pértega-Díaz S, López-Calviño B, López-Muñiz A, García-Falcón T. Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis. Nefrologia. 2012;32(6):782-789. doi: 10.3265/Nefrologia.pre2012.Jul.11465
Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, et al. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. J Ren Nutr. 2005;15(4):427-434. doi: 10.1053/j.jrn.2005.07.007
Sezer S, Elsurer R, Afsar B, Arat Z, Ozdemir NF, Haberal M. Peritoneal Small Solute Transport Rate Is Related to the Malnutrition Inflammation Score in Peritoneal Dialysis Patients. Nephron Clin Pract. 2007;107(4):c156-c162. doi:10.1159/000110051
Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2001;37(1 Suppl 2):S66-70. doi: 10.1053/ajkd.2001.20748
Beto JA, Ramirez WE, Bansal VK. Medical nutrition therapy in adults with chronic kidney disease: integrating evidence and consensus into practice for the generalist registered dietitian nutritionist. J Acad Nutr Diet. 2014;114(7):1077-1087. doi: 10.1016/j.jand.2013.12.009
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3):S1-S107. doi: 10.1053/j.ajkd.2020.05.006
Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int. 1981;19(4):564-567. doi: 10.1038/ki.1981.53
McCarthy MP. Pavlinac JM, Aoun A. Chronic Kidney Disease and the Nutrition Care Process. USA. The Academy of Nutrition and Dietetics; 2014. ISBN:9780880914796
Khan SF, Ronco C, Rosner MH. Counteracting the Metabolic Effects of Glucose Load in Peritoneal Dialysis Patients; an Exercise-Based Approach. Blood Purif. 2019;48(1):25-31. doi: 10.1159/000499406
Kotla SK, Saxena A, Saxena R. A Model To Estimate Glucose Absorption in Peritoneal Dialysis: A Pilot Study. Kidney360. 2020;1(12):1373-1379. doi:10.34067/KID.0004722020
Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis. Kidney Int. 1981;19(4):593-602. doi: 10.1038/ki.1981.57
Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R. Dietary Protein Requirements and Dialysate Protein Losses in Chronic Peritoneal Dialysis Patients. Perit Dial Int. 2007;27(2):192-195. doi:10.1177/089686080702700217
Guedes AM. Peritoneal Protein Loss, Leakage or Clearance in Peritoneal Dialysis, Where do we Stand?. Perit Dial Int. 2019;39(3):201-209. doi:10.3747/pdi.2018.00138
Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096-1107. doi:10.1038/ki.2013.147
Beddhu S, Wei G, Chen X, Boucher R, Kiani R, Raj D, et al. Associations of Dietary Protein and Energy Intakes With Protein-Energy Wasting Syndrome in Hemodialysis Patients. Kidney Int Rep. 2017;2(5):821-830. doi:10.1016/j.ekir.2017.04.002
Otero Alonso P, Pérez Fontán M, López Iglesias A, García Falcón T, Rodríguez-Carmona A. High rates of protein intake are associated with an accelerated rate of decline of residual kidney function in incident peritoneal dialysis patients. Nephrol Dial Transplant. 2019;34(8):1394-1400. doi:10.1093/ndt/gfy393
Doñate T, Borràs M, Coronel F, Lanuza M, González MT, Morey A, et al. Diálisis peritoneal. Consenso de la Sociedad Española de Diálisis y Trasplante. Diálisis y Trasplante. 2006;27(1):23-34. doi: 10.1016/S1886-2845(06)71009-8
Erthal Leinig C, Pecoits-Filho R, Kunii L, Claro LM, Merlin J, Almeida NR de, et al. Low-Fiber Intake Is Associated With High Production of Intraperitoneal Inflammation Biomarkers. J Ren Nutr. 2019;29(4):322-327. doi: 10.1053/j.jrn.2018.10.013
Xu X, Li Z, Chen Y, Liu X, Dong J. Dietary fibre and mortality risk in patients on peritoneal dialysis. Brit J Nutr. 2019;122(9):996-1005. doi: 10.1017/S0007114519001764
Liu X, Hu Z, Xu X, Li Z, Chen Y, Dong J. The associations of plant-based protein intake with all-cause and cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2020;30(6):967-976 doi: 10.1016/j.numecd.2020.03.003
Sánchez-Rodríguez C, Peiró C, Rodríguez-Mañas L, Nevado J. Polyphenols Attenuate Highly-Glycosylated Haemoglobin-Induced Damage in Human Peritoneal Mesothelial Cells. Antioxidants. 2020;9(7):572. doi: 10.3390/antiox9070572
Liebman SE, Le TH. Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease. Nutrients. 2021;13(1). doi: 10.3390/nu13010266
Fanton S, Cardozo LFMF, Combet E, Shiels PG, Stenvinkel P, Vieira IO, et al. The sweet side of dark chocolate for chronic kidney disease patients. Clin Nutr. 2021;40(1):15-26. doi: 10.1016/j.clnu.2020.06.039
Wang AYM, Brimble KS, Brunier G, Brunier G, Holt SG, Jha V, et al. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int. 2015;35(4):379-387. doi: 10.3747/pdi.2014.00279
de Luis D, Bustamante J. Nutritional aspects in renal failure. Nefrologia. 2008;28(3):333-342.
Patel C, Burrowes JD. Chapter 16. Peritoneal Dialysis. En: Burrowes JD, Kovesdy CP, Byham-Gray LD. Nutrition in Kidney Disease. Third Edition. Springer Nature; 2020. ISBN 978-3-030-44858-5
Gluba-Brzózka A, Franczyk B, Rysz J. Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe. Nutrients. 2017;9(4). doi: 10.3390/nu9040374
Stanford J, Charlton K, Stefoska-Needham A, Zheng H, Bird L, Borst A, et al. Associations Among Plant-Based Diet Quality, Uremic Toxins, and Gut Microbiota Profile in Adults Undergoing Hemodialysis Therapy. J Ren Nutr. 2021;31(2):177-188. doi: 10.1053/j.jrn.2020.07.008
Aycart DF, Acevedo S, Eguiguren-Jimenez L, Andrade JM. Influence of Plant and Animal Proteins on Inflammation Markers among Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Nutrients. 2021;13(5):1660. doi: 10.3390/nu13051660.